JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova has submitted newspaper publications of its audited standalone and consolidated financial results for Q4 and the financial year ended March 31, 2026. The results were reviewed by the Audit Committee on May 21, 2026 and approved by the Board of Directors on May 22, 2026. The publications appeared in Financial Express (English) and Hindustan & Jansatta (Hindi) newspapers on May 23, 2026. Complete financial details are accessible via a QR code and a company webpage link, as well as on NSE and BSE websites.
This is a regulatory compliance filing confirming that Q4 and FY2026 financial results have been publicly disclosed through newspapers. The actual financial performance figures would be in the detailed results posted on the company website, not in this submission.